The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: comment

Abstract

To cite this article: Gaboreau Y, Lebelhomme A, Soave C, Imbert P, Couturier P, Bosson JL, Pernod G. The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: comment.

The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: reply

“…It is with great interest we have read the article by Eikelboom et al [1] recently published in The New England Journal of Medicine.…”

“…The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study: reply We were pleased to read the letter from Gaboreau et al [1] related to our recent article [2]. In this article, in a population of elderly patients anticoagulated with warfarin for venous thromboembolism (VTE), we applied available bleeding scores to evaluate their predictive ability for bleeding risk.…”